Page last updated: 2024-09-04

tuftsin and Candidiasis

tuftsin has been researched along with Candidiasis in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Haq, W; Khan, MA; Nasti, HT; Owais, M; Saima Dagger, K; Shehbaz, A; Syed, FM	1
Ahmad, N; Firoz, A; Khan, MA; Mallick, AI; Mohammad, O; Nasti, TH; Saima, K; Wajahul, H	1
Firoz, A; Jabeen, R; Khan, MA; Mohammad, O	1
Khan, A; Khan, MA; Owais, M	1
Khan, MA; Owais, M	1
Amoscato, AA; Babcock, GF; Banks, RA; Nishioka, K; Phillips, JH	1
Hayashi, M; Hisatsune, K; Ishikawa, T; Nogaki, K; Nozaki, S; Ogawa, H	1
Faisal, SM; Haque, W; Masood, AK; Owais, M	1
el-Hagin, T; Hopfer, RL; Lopez-Berestein, G; Nishioka, K	1

Reviews

1 review(s) available for tuftsin and Candidiasis

Article	Year
Tuftsin: an immunomodulating peptide hormone and its clinical potential as a natural biological response modifier. Cancer investigation, 1984, Volume: 2, Issue:1 Topics: Animals; Antibody-Dependent Cell Cytotoxicity; Candidiasis; Cytotoxicity, Immunologic; Humans; Killer Cells, Natural; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Lymphocyte Activation; Macrophages; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Neoplasm Transplantation; Neutrophils; Phagocytosis; Receptors, Cell Surface; Receptors, Immunologic; Tuftsin	1984

Article

Year

Tuftsin: an immunomodulating peptide hormone and its clinical potential as a natural biological response modifier.

Cancer investigation, 1984, Volume: 2, Issue:1

Topics: Animals; Antibody-Dependent Cell Cytotoxicity; Candidiasis; Cytotoxicity, Immunologic; Humans; Killer Cells, Natural; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Lymphocyte Activation; Macrophages; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Neoplasm Transplantation; Neutrophils; Phagocytosis; Receptors, Cell Surface; Receptors, Immunologic; Tuftsin

1984

Other Studies

8 other study(ies) available for tuftsin and Candidiasis

Article	Year
Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B. Journal of drug targeting, 2003, Volume: 11, Issue:2 Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Antibiotic Prophylaxis; Antifungal Agents; Candida albicans; Candidiasis; Cholesterol; Chromatography, High Pressure Liquid; Female; Liposomes; Mice; Mice, Inbred BALB C; Nystatin; Phosphatidylcholines; Tuftsin	2003
Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice. FEMS immunology and medical microbiology, 2004, Jul-01, Volume: 41, Issue:3 Topics: Adjuvants, Immunologic; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Synergism; Drug Therapy, Combination; Female; Liposomes; Mice; Mice, Inbred BALB C; Neutropenia; Nystatin; Treatment Outcome; Tuftsin	2004
Prophylactic role of immunomodulators in treatment of systemic candidiasis in leukopenic mice. Journal of drug targeting, 2004, Volume: 12, Issue:7 Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Compounding; Drug Resistance, Fungal; Female; Immunologic Factors; Intercalating Agents; Kidney; Leukopenia; Lipopolysaccharides; Liposomes; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Nystatin; Staphylococcal Protein A; Tuftsin	2004
Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice. FEMS immunology and medical microbiology, 2006, Volume: 46, Issue:1 Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Drug Resistance, Fungal; Fluconazole; Immunologic Factors; Kidney; Leukopenia; Liposomes; Macrophages; Mice; Mice, Inbred BALB C; Phagocytosis; Tuftsin	2006
Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model. The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Drug Stability; Immunologic Factors; Liposomes; Mice; Mice, Inbred BALB C; Tuftsin	2006
A biochemical study of the phagocytic activities of tuftsin and its analogues. Annals of the New York Academy of Sciences, 1983, Volume: 419 Topics: Animals; Anti-Bacterial Agents; Candidiasis; Cyclophosphamide; Drug Therapy, Combination; Immunosuppression Therapy; Macrophages; Male; Mice; Mice, Inbred ICR; Neutrophils; Phagocytosis; Rabbits; Spleen; Staphylococcus aureus; Thymidine; Tuftsin	1983
Immunomodulator tuftsin augments anti-fungal activity of amphotericin B against experimental murine candidiasis. Journal of drug targeting, 2002, Volume: 10, Issue:3 Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Antifungal Agents; Antigens; Candida albicans; Candidiasis; Disease Models, Animal; Drug Resistance, Fungal; Drug Synergism; Female; Immunoglobulin G; Kidney; Liposomes; Liver; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Spleen; T-Lymphocytes; Tuftsin	2002
Prophylaxis of Candida albicans infection with tuftsin. The Journal of antimicrobial chemotherapy, 1986, Volume: 17, Issue:3 Topics: Animals; Candidiasis; Mice; Time Factors; Tuftsin	1986